UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

Detection of NRG1 Gene Fusions in Solid Tumors

Clinical cancer research, 2019-08, Vol.25 (16), p.4966-4972

2019

Volltextzugriff (PDF)

Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients

Cancer medicine (Malden, MA), 2018-03, Vol.7 (3), p.746-756

2018

Volltextzugriff (PDF)

Personalized Medicine in Oncology; a Special Issue of the Journal of Personalized Medicine

Journal of personalized medicine, 2021-07, Vol.11 (7), p.632

VanderWalde, Ari

2021

Volltextzugriff (PDF)

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

The lancet oncology, 2019-04, Vol.20 (4), p.518-530

2019

Volltextzugriff (PDF)

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer

Molecular cancer therapeutics, 2021-12, Vol.20 (12), p.2577-2584

2021

Volltextzugriff (PDF)

Aging and osteoporosis in breast and prostate cancer

CA: a cancer journal for clinicians, 2011-05, Vol.61 (3), p.139-156

2011

Volltextzugriff (PDF)

Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events

Clinical lung cancer, 2022-12, Vol.23 (8), p.686-693

2022

Volltextzugriff (PDF)

Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial

The lancet oncology, 2015-02, Vol.16 (2), p.221-232

2015

Volltextzugriff (PDF)

Second Malignancies Among Elderly Survivors of Cancer

The oncologist (Dayton, Ohio), 2011-11, Vol.16 (11), p.1572-1581

2011

Volltextzugriff (PDF)

Genomic, immunologic, and prognostic associations of TROP2 ( TACSTD2 ) expression in solid tumors

The oncologist (Dayton, Ohio), 2024-07

2024

Volltextzugriff (PDF)

Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing

BMC cancer, 2023-10, Vol.23 (1), p.1-1000, Article 1000

2023

Volltextzugriff (PDF)

ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes

Scientific reports, 2024-02, Vol.14 (1), p.3444-3444, Article 3444

2024

Volltextzugriff (PDF)

Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

Molecular cancer therapeutics, 2022-01, Vol.21 (1), p.227-236

2022

Volltextzugriff (PDF)

The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer

Molecular cancer therapeutics, 2021-01, Vol.20 (1), p.183-190

2021

Volltextzugriff (PDF)

Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer

Frontiers in oncology, 2023-08, Vol.13, p.1215524-1215524

2023

Volltextzugriff (PDF)

Personalized Medicine in Oncology

VanderWalde, Ari

2022

Volltextzugriff (PDF)

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Clinical cancer research, 2018-12, Vol.24 (24), p.6150-6159

2018

Volltextzugriff (PDF)

Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting

Journal of personalized medicine, 2020-11, Vol.10 (4), p.252

2020

Volltextzugriff (PDF)

Precision Medicine in Oncology: A Review of Multi-Tumor Actionable Molecular Targets with an Emphasis on Non-Small Cell Lung Cancer

Journal of personalized medicine, 2021-06, Vol.11 (6), p.518

2021

Volltextzugriff (PDF)

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases

NPJ precision oncology, 2023-11, Vol.7 (1), p.120-120, Article 120

2023

Volltextzugriff (PDF)

180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A204-A204

2023

Volltextzugriff (PDF)

Early Breast Cancer in the Older Woman

Clinics in geriatric medicine, 2012-02, Vol.28 (1), p.73-91

2012

Volltextzugriff (PDF)

1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal undifferentiated carcinoma (SNUC)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1674-A1674

2023

Volltextzugriff (PDF)

1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1673-A1673

2023

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(144)

Publikationsform

Artikel
(148)
Berichte
(2)
Bücher
(1)

Sprache

Englisch
(151)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Detection of NRG1 Gene Fusions in Solid Tumors

Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients

Personalized Medicine in Oncology; a Special Issue of the Journal of Personalized Medicine

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer

Aging and osteoporosis in breast and prostate cancer

Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events

Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial

Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial

Second Malignancies Among Elderly Survivors of Cancer

Genomic, immunologic, and prognostic associations of TROP2 ( TACSTD2 ) expression in solid tumors

Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing

ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes

Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer

Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer

Personalized Medicine in Oncology

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting

Precision Medicine in Oncology: A Review of Multi-Tumor Actionable Molecular Targets with an Emphasis on Non-Small Cell Lung Cancer

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases

180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma

Early Breast Cancer in the Older Woman

1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal undifferentiated carcinoma (SNUC)

1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC)

Suchergebnisse filtern